文献速递主动脉疾病

胸主动脉腔内修复术2区孤立左锁骨下动脉血运重建两种技术的比较

Comparison of Two Different Techniques for Isolated Left Subclavian Artery Revascularization During Thoracic Endovascular Aortic Repair in Zone 2.
PubMed 文献 · J Endovasc Ther · 2018-10-04

回顾性多中心观察研究纳入73例急慢性胸主动脉病变患者,在TEVAR 2区行孤立左锁骨下动脉血运重建,比较颈动脉-锁骨下动脉旁路(CSbp,n=42)与烟囱移植物(CGs,n=31)两种技术。两组早期TEVAR相关死亡率、卒中、Ia型内漏免除率及左锁骨下动脉通畅率无显著差异。

要点

  • CSbp与CGs两组早期TEVAR相关死亡率分别为2%与6%,差异无统计学意义(p=0.571)。
  • 两组各发生1例重大缺血性卒中,Ia型内漏免除率CSbp 98% vs CG 87%(p=0.134)。
  • CG组4例(13%)出现与移植物间隙相关的内漏,但均无瘤囊增大、无再干预、无死亡。

核心结论

  • 作者经验认为,CSbp与CGs两种左锁骨下动脉血运重建技术均令人满意且同等有效,中期随访未见可辨别的差异。

研究设计与样本

  • 回顾性多中心观察性研究,纳入2010年1月至2017年2月期间73例(平均年龄68±13岁,范围22-87岁;56例男性)接受TEVAR联合孤立左锁骨下动脉血运重建的急慢性胸主动脉病变患者,其中CSbp组42例、CGs组31例。

主要发现

  • 所有病例均获得初期技术成功。
  • 早期TEVAR相关死亡率为4.2%(CSbp组2% vs CG组6%,p=0.571)。
  • 2例(3%)患者发生重大缺血性卒中,每组各1例。
  • 平均随访24±21个月(范围1-72个月;中位数15个月),估计12个月和36个月TEVAR相关死亡免除率为93%±3%(95%CI 84.3%至97.0%),CSbp与CG组间无显著差异(p=0.258)。
  • 主动脉再干预率组间无差异(CSbp组5% vs CG组6%,p=0.356);Ia型内漏免除率亦无差异(CSbp组98% vs CG组87%,p=0.134)。CG组4例(13%)出现与移植物间隙相关的内漏,但均无瘤囊增大、无再干预需要、无死亡。观察期内全组左锁骨下动脉一期通畅率为100%。

关键数值与推荐

  • 主要终点为TEVAR相关死亡、术后卒中、Ia型内漏免除率及左锁骨下动脉通畅率。
  • 早期TEVAR相关死亡率:CSbp组2% vs CG组6%(p=0.571)。
  • 重大缺血性卒中:每组各1例(共2例,3%)。
  • Ia型内漏免除率:CSbp组98% vs CG组87%(p=0.134)。
  • 主动脉再干预率:CSbp组5% vs CG组6%(p=0.356)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To analyze the results of isolated left subclavian artery (LSA) revascularization during thoracic endovascular aortic repair (TEVAR) using carotid-subclavian bypass (CSbp) or chimney grafts (CGs). METHODS: A retrospective multicenter, observational study identified 73 patients (mean age 68±13 years, range 22-87; 56 men) with acute or chronic thoracic aortic lesions who underwent TEVAR with isolated LSA revascularization using either CSbp (n=42) or CGs (n=31) from January 2010 and February 2017. Primary endpoints were TEVAR-related mortality, postoperative stroke, freedom from type Ia endoleak, and LSA patency. RESULTS: Primary technical success was achieved in all cases. Early TEVAR-related mortality was 4.2% (CSbp 2% vs CG 6%, p=0.571). Two (3%) patients had major ischemic strokes (one in each group). Mean follow-up was 24±21 months (range 1-72; median 15). Estimated freedom from TEVAR-related mortality was 93%±3% (95% CI 84.3% to 97.0%) at 12 and 36 months, with no significant difference between CSbp and CG (p=0.258). Aortic reintervention did not differ between the groups (CSbp 5% vs CG 6%, p=0.356); nor did freedom from type Ia endoleak (CSbp 98% vs CG 87%, p=0.134). Gutter-related endoleaks occurred in 4 (13%) CG patients, but none of the patients experienced sac enlargement or the need for reintervention and none died. Primary patency of the LSA was 100% for the entire group during the observation period. CONCLUSION: In our experience, LSA revascularization proved most satisfactory and equally effective with both the CSbp and CG techniques, without discernible differences at midterm follow-up.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Piffaretti G, Pratesi G, Gelpi G, et al. Comparison of Two Different Techniques for Isolated Left Subclavian Artery Revascularization During Thoracic Endovascular Aortic Repair in Zone 2. J Endovasc Ther. 2018. PMID: 30284491. doi:10.1177/1526602818802581

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。